fda compounding semaglutide warning september 2025 letters Compounded " semaglutide" is not FDA-approved FDA issues 30 warning letters – FDA warns telehealth providers over

Weight loss typically begins within the first month, although the rate varies depending on the dose, diet, exercise, and individual metabolism

Whether microdosing makes sense for you depends on factors most online discussions never mention

Rosenstock reported that body weight loss of almost 17% was achieved with the 8 mg and 12 mg doses at week 36, without showing a plateau

Clinical studies show that retatrutide could be the most powerful drug to be developed for the treatment of obesity

A lower negotiated price is expected to begin in 2027

Glucagon-like peptide-1 (GLP-1) receptor agonists are temperature-sensitive biological medications that require careful storage to maintain their therapeutic efficacy